Efficacy and safety of levofloxacin-based Helicobacter pylori eradication regime compared to conventional first-line therapy

被引:0
|
作者
Aizan, H. [1 ]
Sheikh, A. A. [1 ]
Ong, T. Z. [1 ]
机构
[1] Univ Kebangsaan Malaysia, Shah Alam, Malaysia
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A81 / A81
页数:1
相关论文
共 50 条
  • [41] Levofloxacin/azithromycin-based triple therapies as first-line treatment for Helicobacter pylori eradication
    Gisbert, J. P.
    Gisbert, J. L.
    Marcos, S.
    Moreno-Otero, R.
    Pajares, J. M.
    [J]. HELICOBACTER, 2006, 11 (04) : 385 - 385
  • [42] Comparison of different second-line levofloxacin-based triple schemes for Helicobacter pylori eradication
    Di caro, Simona
    Raimondo, Dario
    Mariam, Alberto
    Masci, Enzo
    Testoni, Pier A.
    La rocca, Ennio
    [J]. GASTROENTEROLOGY, 2007, 132 (04) : A112 - A112
  • [43] Second-Line Levofloxacin-Based Triple Therapy's Efficiency for Helicobacter pylori Eradication in Patients With Peptic Ulcer
    Ermis, Fatih
    Akyuz, Filiz
    Uyanikoglu, Ahmet
    Kurt, Ramazan
    Pinarbasi, Binnur
    Nazik, Hasan
    Kaymakoglu, Sabahattin
    Mungan, Zeynel
    [J]. SOUTHERN MEDICAL JOURNAL, 2011, 104 (08) : 579 - 583
  • [44] Rifaximin Plus Levofloxacin-Based Rescue Regimen for the Eradication of Helicobacter pylori
    Yun, Sang-Pil
    Seon, Han Gyung
    Ok, Chang Soo
    Yoo, Kwang Ho
    Kang, Min Kyung
    Kim, Won Hee
    Kwon, Chang Ii
    Ko, Kwang Hyun
    Hwang, Seong Gyu
    Park, Pil Won
    Hong, Sung Pyo
    [J]. GUT AND LIVER, 2012, 6 (04) : 452 - 456
  • [45] Levofloxacin based triple therapy for third line Helicobacter pylori eradication
    Lee, M.
    Kim, G.
    Lee, B.
    Song, G.
    Park, S.
    Park, S.
    Park, J.
    Kim, S.
    [J]. HELICOBACTER, 2018, 23
  • [46] EFFICACY OF CONCOMITANT NONBITHMUTH-BASED QUADRUPLE THERAPY AS FIRST-LINE TREATMENT FOR ERADICATION OF HELICOBACTER PYLORI
    Moon, B.
    Lim, H.
    Lee, S.
    Han, K.
    Chung, J.
    Lee, Y.
    [J]. HELICOBACTER, 2011, 16 : 131 - 132
  • [47] Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori
    Yang, Jing
    Zhang, Yi
    Fan, Ling
    Zhu, Yang-Jie
    Wang, Ting-Yi
    Wang, Xing-Wei
    Chen, Dong-Feng
    Lan, Chun-Hui
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (03): : 437 - 445
  • [48] ARE QUADRUPLE LEVOFLOXACIN-BASED REGIMENS AN EFFECTIVE ALTERNATIVE TO STANDARD SEQUENTIAL THERAPY IN THE ERADICATION OF HELICOBACTER PYLORI?
    Branquinho, D.
    Almeida, N.
    Fernandes, A.
    Casela, A.
    Pina Cabral, J.
    Gregorio, C.
    Donato, M.
    Calhau, C.
    Romaozinho, J.
    Sofia, C.
    [J]. HELICOBACTER, 2015, 20 : 95 - 95
  • [49] Bismuth quadruple therapy versus levofloxacin triple therapy for first-line helicobacter pylori eradication treatment: multicenter study
    Tran Thi Khanh Tuong
    Huynh Quang Huy
    Tong Nguyen Diem Hong
    Nguyen Thi Anh Dao
    Ngo Thi Thanh Quyt
    [J]. MEDICAL SCIENCE, 2020, 24 (104) : 2245 - 2250
  • [50] Levofloxacin and proton pump inhibitor-based triple therapy versus standard triple first-line therapy for Helicobacter pylori eradication
    Ye, Chen-Li
    Liao, Guo-Ping
    He, Shuai
    Pan, Yan-Na
    Kang, Ying-Bo
    Zhang, Zhong-Yi
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (05) : 443 - 455